These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 18837768

  • 1. Low-molecular-weight heparin for routine hemodialysis.
    Davenport A.
    Hemodial Int; 2008 Oct; 12 Suppl 2():S34-7. PubMed ID: 18837768
    [Abstract] [Full Text] [Related]

  • 2. The rationale for the use of low molecular weight heparin for hemodialysis treatments.
    Davenport A.
    Hemodial Int; 2013 Oct; 17 Suppl 1():S28-32. PubMed ID: 24134328
    [Abstract] [Full Text] [Related]

  • 3. Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments.
    Davenport A.
    Nephrology (Carlton); 2009 Aug; 14(5):455-61. PubMed ID: 19674314
    [Abstract] [Full Text] [Related]

  • 4. The safety of heparins in end-stage renal disease.
    Sonawane S, Kasbekar N, Berns JS.
    Semin Dial; 2006 Aug; 19(4):305-10. PubMed ID: 16893408
    [Abstract] [Full Text] [Related]

  • 5. Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies.
    Sagedal S, Hartmann A.
    Eur J Med Res; 2004 Mar 30; 9(3):125-30. PubMed ID: 15096322
    [Abstract] [Full Text] [Related]

  • 6. [Present opinions concerning the administration of low molecular weight heparins in hemodialysis patients].
    Drozdz M, Kowalczyk-Michałek M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2005 Mar 30; 62(4):257-9. PubMed ID: 16229247
    [Abstract] [Full Text] [Related]

  • 7. Comparison of anticoagulation efficacy and clinical safety between imported and domestically manufactured low-molecular-weight heparin during hemodialysis.
    Liu ZQ, Wang L.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct 30; 22(10):942-3. PubMed ID: 12377628
    [Abstract] [Full Text] [Related]

  • 8. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K.
    Blood Coagul Fibrinolysis; 1993 Dec 30; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [Abstract] [Full Text] [Related]

  • 9. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL, Ansell JE.
    Clin Geriatr Med; 2006 Feb 30; 22(1):1-15, vii. PubMed ID: 16377464
    [Abstract] [Full Text] [Related]

  • 10. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
    Thompson-Ford JK.
    Pharmacotherapy; 1998 Feb 30; 18(4):748-58. PubMed ID: 9692649
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with nadroparin in patients undergoing dialysis for renal impairment.
    Zhang W, Chen X, Chen Y, Chen N.
    Hemodial Int; 2011 Jul 30; 15(3):379-94. PubMed ID: 21722301
    [Abstract] [Full Text] [Related]

  • 12. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK, Dogukan A, Yalniz M, Seckin D, Gunal AL.
    Ren Fail; 2006 Jul 30; 28(8):723-7. PubMed ID: 17162433
    [Abstract] [Full Text] [Related]

  • 13. Low molecular weight heparin and bleeding in patients with chronic renal failure.
    Crowther M, Lim W.
    Curr Opin Pulm Med; 2007 Sep 30; 13(5):409-13. PubMed ID: 17940486
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD, Müller U, Lanzmich R, Groeger C, Floege J.
    Nephrol Dial Transplant; 2006 Apr 30; 21(4):1013-8. PubMed ID: 16326745
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight heparins in patients with renal insufficiency.
    Symes J.
    CANNT J; 2008 Apr 30; 18(2):55-61. PubMed ID: 18669012
    [Abstract] [Full Text] [Related]

  • 16. Optimization of heparin anticoagulation for hemodialysis.
    Davenport A.
    Hemodial Int; 2011 Oct 30; 15 Suppl 1():S43-8. PubMed ID: 22093600
    [Abstract] [Full Text] [Related]

  • 17. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
    Sabry A, Taha M, Nada M, Al Fawzan F, Alsaran K.
    Blood Coagul Fibrinolysis; 2009 Jan 30; 20(1):57-62. PubMed ID: 20523166
    [Abstract] [Full Text] [Related]

  • 18. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP, Chouraqui D, Lobbedez T.
    Nephrologie; 1998 Jan 30; 19(4):223-5. PubMed ID: 9675763
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Use of low-molecular weight heparin during hemodialysis].
    Kalinowski M, Pawlak K, Myśliwiec M, Popławski A.
    Pol Merkur Lekarski; 1997 Jan 30; 2(9):208-10. PubMed ID: 10907031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.